ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA

This study is testing whether adding the drug tazemetostat to standard CHOP chemotherapy works better for people with newly diagnosed T cell lymphoma. About 24 participants will receive the combination treatment, and researchers will measure how well the cancer responds and how l…

This study aims to see if adding one of two new drugs (duvelisib or CC-486) to a standard chemotherapy regimen works better for treating newly diagnosed peripheral T-cell lymphoma, a rare and aggressive blood cancer. It will compare the complete remission rates and side effects b…

This study is testing a new treatment approach for aggressive types of T-cell lymphoma, a rare blood cancer. It combines a targeted drug that seeks out cancer cells with standard chemotherapy drugs. The goal is to see if this combination is safe and more effective at controlling …

This study is testing whether giving vitamin D supplements to cancer patients who have low vitamin D levels can help improve their survival and delay the need for other treatments. It focuses on people newly diagnosed with certain aggressive lymphomas or a slow-growing type of le…

This study is testing a personalized plan to manage cytomegalovirus (CMV), a common and potentially serious infection, in patients who have received a donor stem cell transplant for blood cancers or disorders. The plan involves closely monitoring the virus level and the patient's…